凉血消疕丸联合阿维A治疗红皮病型银屑病临床观察

Clinical Observation of Liangxue Xiaobi Pills Combined with Acitretin in Treating Erythrodermic Psoriasis

目的:观察凉血消疕丸联合阿维A治疗红皮病型银屑病(EP)的临床疗效。方法:选取符合临床诊断标准的60例EP患者,将其随机分为对照组和观察组各30例。对照组治疗采用阿维A胶囊口服,观察组在对照组治疗基础上加用凉血消疕丸口服,疗程都是6周。观察两组治疗后的临床总有效率及治疗前后的严重程度指数(PASI)。结果:两组总有效率和PASI评分比较,差异有统计学意义(P<0.05)。结论:应用凉血消疕丸联合阿维A治疗EP患者临床疗效明确,可显著减少患者的皮损面积,降低PASI评分。

Objective:To observe the clinical efficacy of Liangxue Xiaobi Pills combined with Acitretin in the treatment of erythrodermic psoriasis(EP).Methods:60 cases of clinical inclusion criteria conform EP were randomly divided into control group and observation group,30 cases in each group.The control group was treated with Acitretin capsules orally,and the observation group was treated with Liangxue Xiaobi Pills on the basis of the control group.The course of treatment is 6 weeks.Clinical Observation on the total efficiency of two groups after treatment,and the effect of treatment severity index(PASI).Results:The total effective rate and the comparison of PASI scores between the two groups,the difference was statistically significant(P<0.05).Conclusion:The clinical efficacy of Liangxue Xiaobi Pills combined with Acitretin in the treatment of EP patients is clear and can be significant Reduce the area of the patient’s skin lesions and lower the PASI score.